The majority of Americans now believe these medications are more effective than traditional weight loss methods like diet and exercise.
Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...
Clinical research by Zepbound's manufacturer Eli Lilley found that the drug's active ingredient tirzepatide reduces sleep apnea by about 60%.
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...
The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
At her Thanksgiving table in 2024, half of Ashley Dunham's guests were on a GLP-1 weight loss drug. She made green beans for ...